tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APTOF Stock Latest News

Aptose Reschedules Special Meeting on Hanmi Acquisition Plan
Company AnnouncementsAptose Reschedules Special Meeting on Hanmi Acquisition Plan
2M ago
8K
Aptose Biosciences Unveils Promising AML Therapy Data
PremiumCompany Announcements
Aptose Biosciences Unveils Promising AML Therapy Data
2M ago
8K
Aptose’s Tuspetinib Shows Promising Results in AML Treatment
PremiumCompany Announcements
Aptose’s Tuspetinib Shows Promising Results in AML Treatment
2M ago
Aptose Biosciences to be Acquired by Hanmi Pharmaceuticals
PremiumCompany Announcements
Aptose Biosciences to be Acquired by Hanmi Pharmaceuticals
2M ago
8K
Aptose Biosciences downgraded to Neutral from Buy at Alliance Global
PremiumThe Fly
Aptose Biosciences downgraded to Neutral from Buy at Alliance Global
2M ago
Aptose Biosciences to be Acquired by Hanmi Pharmaceutical
PremiumCompany AnnouncementsAptose Biosciences to be Acquired by Hanmi Pharmaceutical
3M ago
Aptose Biosciences Reports Financial Challenges in Q3 2025
Premium
Company Announcements
Aptose Biosciences Reports Financial Challenges in Q3 2025
3M ago
Aptose Biosciences Reports Promising Results in AML Therapy Trials
Premium
Company Announcements
Aptose Biosciences Reports Promising Results in AML Therapy Trials
3M ago
Aptose Biosciences’ TUSCANY Study Highlighted at ASH 2025
PremiumCompany Announcements
Aptose Biosciences’ TUSCANY Study Highlighted at ASH 2025
3M ago
8K
Aptose Biosciences’ Tuspetinib Study: A Potential Game-Changer in Leukemia Treatment
PremiumCompany Announcements
Aptose Biosciences’ Tuspetinib Study: A Potential Game-Changer in Leukemia Treatment
3M ago
APTOF
Aptose’s Tuspetinib Shows Promising Results in AML Treatment Trial
PremiumCompany Announcements
Aptose’s Tuspetinib Shows Promising Results in AML Treatment Trial
4M ago
Aptose Secures $11.9M Loan for AML Therapy Development
PremiumCompany Announcements
Aptose Secures $11.9M Loan for AML Therapy Development
4M ago
Aptose Biosciences Announces Executive Retention Awards
PremiumCompany AnnouncementsAptose Biosciences Announces Executive Retention Awards
5M ago
8K
Aptose Biosciences Secures Funding for Drug Development
Premium
Company Announcements
Aptose Biosciences Secures Funding for Drug Development
5M ago
8K
Aptose Biosciences Appoints New Independent Auditor
Premium
Company Announcements
Aptose Biosciences Appoints New Independent Auditor
5M ago
8K
Aptose Biosciences Reports Positive Early Data from TUSCANY Trial for AML Treatment
PremiumCompany Announcements
Aptose Biosciences Reports Positive Early Data from TUSCANY Trial for AML Treatment
6M ago
Aptose Biosciences Reports Promising Q2 2025 Results
PremiumCompany Announcements
Aptose Biosciences Reports Promising Q2 2025 Results
6M ago
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
PremiumCompany Announcements
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
6M ago
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
PremiumCompany Announcements
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
6M ago
8K
Aptose Biosciences Appoints Ernst & Young as New Auditor
PremiumCompany AnnouncementsAptose Biosciences Appoints Ernst & Young as New Auditor
6M ago
Aptose Biosciences Secures $2M Advance for AML Therapy
Premium
Company Announcements
Aptose Biosciences Secures $2M Advance for AML Therapy
7M ago
8K
Aptose Biosciences Upgrades to OTCQB Market Listing
Premium
Company Announcements
Aptose Biosciences Upgrades to OTCQB Market Listing
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >